The PDGFRβ(S)J conditional knockin allele has the endogenous PDGFRβ sequences replaced with a floxed-STOP cassette upstream of the constitutively active PDGFRβJ mutant isoform (V536A mutation in the juxtamembrane domain). Following Cre recombinase-mediated excision of the floxed-STOP cassette, expression of the constitutively active mutant PDGFRβ leads to high basal kinase activity without the addition of ligand. These mutant mice may be useful in studying PDGFR signaling in multipotent progenitor mural cells (pericytes and vascular smooth muscle cells), as well as in cardiovascular and obesity-related disease.
Dr. Philippe Soriano, Mount Sinai School of Medicine
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Conditional ready (e.g. floxed), No functional change) | Pdgfrb | platelet derived growth factor receptor, beta polypeptide |
The PDGFRβ(S)J conditional knockin allele has the endogenous PDGFRβ sequences replaced with a loxP-flanked PGKneo (lox-stop-lox) cassette upstream of the constitutively active PDGFRβJ mutant isoform (V536A mutation in the juxtamembrane domain disrupts a highly conserved juxtamembrane region in type III receptor tyrosine kinases that contacts the kinase domain important for full auto-inhibition, leading to constitutive PDGFRβ activity). Prior to Cre recombinase exposure, no expression of the constitutively active βJ mutant isoform is observed, and the mutant allele functions as a knockout. Mice homozygous for the PDGFRβ(S)J allele are neonatal lethal. Heterozygous PDGFRβ(S)J mice are viable and fertile with no reported abnormalities. Following Cre recombinase-mediated excision of the floxed-STOP cassette, high basal kinase activity without the addition of ligand is observed in the cre-expressing tissues.
Of note, pan-deletion of the floxed-STOP cassette can be achieved by breeding PDGFRβ(S)J conditional knockin mice with mice expressing Cre recombinase in early embryonic development (Meox2-Cre [Stock No. 003755], Sox2-Cre [Stock No. 004783], or Prm-Cre [Stock No. 003328]). In the resulting double mutant offspring, widespread expression of the constitutively active PDGFRβ leads to normal embryonic development but eventual death by ~14 days of age. In these double mutant mice, constitutively active PDGFRβ induces a battery of immune response genes in pericytes and mesenchymal cells, and also inhibits in vitro differentiation of white adipocytes.
When PDGFRβ(S)J conditional knockin mice are bred to Sm22-Cre mice [Stock No. 004746], constitutively active PDGFRβ drives cell proliferation and downregulates differentiation genes in aortic vascular smooth muscle tissues of the double mutant offspring.
Importantly, the donating investigator reports they have not observed any consistent phenotypic differences between the Cre recombinase-activated phenotypes of PDGFRβJ and PDGFRβK (see Stock No. 018435) mice, regardless of Cre recombinase tissue specificity.
To create the PDGFRβ(S)J targeting vector, Dr. Philippe Soriano (Mount Sinai School of Medicine) isolated a full-length mouse platelet derived growth factor β (Pdgfrb) cDNA sequence and introduced a valine to alanine substitution at codon 536 (V536A) of the juxtamembrane domain by site-directed mutagenesis. This βJ mutation results in a constitutively active mutant PDGFRβ. A loxP-flanked PGKneo cassette (lox-stop-lox) was placed between the splice acceptor and the initiating codon of the mutant cDNA sequence. This construct replaced the endogenous Pdgfrb exons 2-4 via electroporation into 129S4/SvJaeSor-derived AK7 embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient blastocysts, and the resulting chimeric males were mated with females to generate the PDGFRβ(S)J knockin mouse line. Mutant mice were bred to B6;129 mice harboring other mutations/transgenes, and/or to C57BL/6J wildtype, and/or C57BL/6NTac wildtype mice for several generations prior to sending to The Jackson Laboratory Repository. The donating investigator reports selecting PDGFRβ(S)J mice with no other mutations present for breeding. Upon arrival, mutant mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish The Jackson Laboratory Repository colony.
Allele Name | targeted mutation 13, Philippe Soriano |
---|---|
Allele Type | Targeted (Conditional ready (e.g. floxed), No functional change) |
Allele Synonym(s) | PDGFRbeta(S)J |
Gene Symbol and Name | Pdgfrb, platelet derived growth factor receptor, beta polypeptide |
Gene Synonym(s) | |
Strain of Origin | 129S4/SvJaeSor |
Chromosome | 18 |
Molecular Note | Exons 2 and 3 were replaced with a splice acceptor, floxed neo/stop cassette, and the mouse cDNA with nucleotide substitution(s) that results in the amino acid substitution of alanine for valine at position 536 (V536A). This mutation is an activating mutation. |
Mutations Made By | Dr. Philippe Soriano, Mount Sinai School of Medicine |
When maintaining a live colony, heterozygous mice may be bred to wildtype mice from the colony or with C57BL/6J inbred mice (Stock No. 000664). Homozygous mice die shortly after birth.
When using the STOCK Pdgfrbtm13(Pdgfrb)Sor/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #018434 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or Wildtype for Pdgfrb<tm13(Pdgfrb)Sor> |
Frozen Mouse Embryo | STOCK Pdgfrb<tm13(Pdgfrb)Sor>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Pdgfrb<tm13(Pdgfrb)Sor>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Pdgfrb<tm13(Pdgfrb)Sor>/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | STOCK Pdgfrb<tm13(Pdgfrb)Sor>/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.